Literature DB >> 21256203

A novel in vitro pancreatic carcinogenesis model.

Hyo Jin Kang1, Young Bin Hong, Hee Jeong Kim, Yong Weon Yi, Raghu G Nath, Young Soo Chang, Ho-Chan Cho, Insoo Bae.   

Abstract

Environmental factors (e.g., BaP) have been pointed out as one of the etiologies of pancreatic cancer. However, very limited experimental assays are available to identify pancreatic specific environmental mutagens or susceptibility genes. In this study, we have developed a simple in vitro cell culture model system that can be used to study the molecular and biochemical aspects of carcinogenesis in a near-normal immortalized pancreatic ductal epithelial cell lines. In order to demonstrate that xenobiotic stress response is intact in these cells, we employed standard molecular biology techniques. For examples, luciferase reporter and/or real-time quantitative PCR assays were used to determine stress-induced CYP1A1 and CYP1B1 gene expression. Western blotting and immunocytochemistry assays were used to demonstrate that TCDD or BaP could activate AhR signaling. For exploring the carcinogenesis mechanism, we incubated cells with [³H]BaP and determined BaP-DNA binding activity by measuring its radioactivity. BaP-DNA adduct formation was further confirmed by [³²P]-postlabeling assay. Finally, we demonstrated the effects of endogenous AhR or BRCA1 in BaP-DNA adduct accumulation in our cell system. As results, no apparent BaP-DNA adduct accumulation by [³²P]-postlabeling assay was found in either control-siRNA or AhR-siRNA pretreated cells. On the other hand, a significant increase of BaP-DNA adduct accumulation was found in BRCA1 knockdown cells. In conclusion, we suggest that this in vitro model may provide the feasibility for future studies on the molecular basis of pancreatic ductal cell carcinogenesis caused by dietary mutagens.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256203      PMCID: PMC3052416          DOI: 10.1016/j.toxlet.2011.01.012

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  56 in total

Review 1.  Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems.

Authors:  Kotoko Nakata; Yoshitomo Tanaka; Tatsuya Nakano; Tatsuhiko Adachi; Hiroshi Tanaka; Tsuguchika Kaminuma; Toshihisa Ishikawa
Journal:  Drug Metab Pharmacokinet       Date:  2006-12       Impact factor: 3.614

Review 2.  Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?

Authors:  Richard Kim; Muhammad Wasif Saif
Journal:  JOP       Date:  2007-05-09

Review 3.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

4.  Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice.

Authors:  Volker M Arlt; Marie Stiborová; Colin J Henderson; Markus Thiemann; Eva Frei; Dagmar Aimová; Rajinder Singh; Gonçalo Gamboa da Costa; Oliver J Schmitz; Peter B Farmer; C Roland Wolf; David H Phillips
Journal:  Carcinogenesis       Date:  2008-01-19       Impact factor: 4.944

5.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

6.  The 32P-postlabeling assay for DNA adducts.

Authors:  David H Phillips; Volker M Arlt
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression.

Authors:  Hyo Jin Kang; Hee Jeong Kim; Jeong-Keun Rih; Thomas L Mattson; Kyu Won Kim; Chi-Heum Cho; Jennifer S Isaacs; Insoo Bae
Journal:  J Biol Chem       Date:  2006-03-16       Impact factor: 5.157

Review 8.  Epidemiology and risk factors for pancreatic cancer.

Authors:  Albert B Lowenfels; Patrick Maisonneuve
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006-04       Impact factor: 3.043

9.  The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers.

Authors:  Enrique Zudaire; Natalia Cuesta; Vundavalli Murty; Karen Woodson; Lisa Adams; Nieves Gonzalez; Alfredo Martínez; Gopeshwar Narayan; Ilan Kirsch; Wilbur Franklin; Fred Hirsch; Michael Birrer; Frank Cuttitta
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).

Authors: 
Journal:  Natl Toxicol Program Tech Rep Ser       Date:  2006-09
View more
  1 in total

1.  Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cells.

Authors:  Hyo Jin Kang; Young Bin Hong; Hee Jeong Kim; Antai Wang; Insoo Bae
Journal:  Toxicol Lett       Date:  2011-12-13       Impact factor: 4.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.